Similarly, a previous study about hepatocellular carcinoma suggested that the activation of the AKT/mTOR pathway could elevate the expression of SREBP1-c and then reprogram hepatic lipid metabolism [58]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.